Trial Profile
Functional Neuroimaging of Acute Concerta Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD): Differences Across Development.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Jul 2012
Price :
$35
*
At a glance
- Drugs Methylphenidate (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Biomarker; Pharmacodynamics
- 09 Dec 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 Jan 2010 Planned end date changed from 1 Jan 2010 to 1 Jul 2010 as reported by ClinicalTrials.gov.
- 18 Apr 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.